112
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Longitudinal change of FEV1 and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD

, , , , , , & show all
Pages 361-369 | Published online: 04 Feb 2019

References

  • ManninoDMBramanSThe epidemiology and economics of chronic obstructive pulmonary diseaseProc Am Thorac Soc20074750250617878461
  • HwangYIParkYBYooKHRecent trends in the prevalence of chronic obstructive pulmonary disease in KoreaTuberc Respir Dis (Seoul)201780322622928747954
  • YoonHKParkYBRheeCKLeeJHOhYMCommittee of the Korean COPD Guideline 2014Summary of the chronic obstructive pulmonary disease clinical practice guideline revised in 2014 by the Korean Academy of tuberculosis and respiratory diseaseTuberc Respir Dis (Seoul)201780323024028747955
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2017 update Available from: http://www.goldcopd.orgAccessed June 14, 2017
  • CelliBRMacNeeWAgustiAATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • CaoZOngKCEngPTanWCNgTPFrequent hospital readmissions for acute exacerbation of COPD and their associated factorsRespirology200611218819516548905
  • NishimuraKIzumiTTsukinoMOgaTDyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPDChest200212151434144012006425
  • FranciosiLGPageCPCelliBRMarkers of disease severity in chronic obstructive pulmonary diseasePulm Pharmacol Ther200619318919916019244
  • HanMKMuellerovaHCurran-EverettDGold 2011 disease severity classification in COPDGene: a prospective cohort studyLancet Respir Med201311435024321803
  • JonesPWHealth status and the spiral of declineCOPD200961596319229709
  • RossiAAisanovZAvdeevSMechanisms, assessment and therapeutic implications of lung hyperinflation in COPDRespir Med2015109778580225892293
  • O’DonnellDEGuenetteJAMaltaisFWebbKADecline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exerciseChest2012141375376221852298
  • CasanovaCCoteCde TorresJPInspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171659159715591470
  • ZamanMMahmoodSAltayehALow inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbationAm J Med Sci2010339541141420375693
  • TantucciCDonatiPNicosiaFInspiratory capacity predicts mortality in patients with chronic obstructive pulmonary diseaseRespir Med2008102461361918083020
  • O’DonnellDECasaburiRFrithPEffects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPDEur Respir J2017494160134828424359
  • FujimotoKYamazakiHUraMKitaguchiYEfficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover studyInt J Chron Obstruct Pulmon Dis2017123195320129138547
  • SalomonJStolzDDomenighettiGIndacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled studyRespir Res20171811328077140
  • CalzettaLOraJCavalliFRoglianiPO’DonnellDECazzolaMImpact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: a pair-wise and network meta-analysisRespir Med201712918919828732830
  • LeeJYChonGRRheeCKCharacteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: the Korea COPD subgroup Study Team cohortJ Korean Med Sci201631455356027051239
  • WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
  • CriéeCPSorichterSSmithHJBody plethysmography – its principles and clinical useRespir Med2011105795997121356587
  • ChoiJKPaekDLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis2005583230242
  • DonohueJFMinimal clinically important differences in COPD lung functionCOPD20052111112417136971
  • CazzolaMMacNeeWMartinezFJOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J200831241646918238951
  • O’DonnellDERevillSMWebbKADynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2001164577077711549531
  • CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
  • CoteCGSurrogates of mortality in chronic obstructive pulmonary diseaseAm J Med2006119105462
  • DonaldsonGCWedzichaJACOPD exacerbations 1: EpidemiologyThorax200661216416816443707
  • FlattetYGarinNSerratriceJPerrierAStirnemannJCarballoSDetermining prognosis in acute exacerbation of COPDInt J Chron Obstruct Pulmon Dis20171246747528203070
  • DonaldsonGCMüllerovaHLocantoreNFactors associated with change in exacerbation frequency in COPDRespir Res20131417923899210
  • HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • FreiASiebelingLWoltersCThe inaccuracy of patient recall for COPD exacerbation rate estimation and its implications: results from central adjudicationChest2016150486086827400907
  • YanSKaminskiDSliwinskiPReliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1997156155599230726
  • BelmanMJBotnickWCShinJWInhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199615339679758630581
  • KannerREAnthonisenNRConnettJELung Health Study Research GroupLower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
  • MenezesAMBMontes de OcaMPérez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
  • López-CamposJLPeces-BarbaGSoler-CataluñaJJChronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. study methods and organizationArch Bronconeumol2012481245345922766419